Sources | Names Used |
---|---|
CTRPv2 | navitoclax:MST-312 (1:1 mol/mol) |
PharmacoGx | navitoclax:MST-312 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LPCAT3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
mRNA | METAP2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | EMC6 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | FBXO15 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
mRNA | AEBP1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | TTLL9 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | RP13-347D8.7 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | OSTC | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | ABCC3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | SNAP47 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |